Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged ≥18 years.
Moderate to severe activity of rheumatoid arthritis (DAS28 ≥3.2).
Patient for whom the physician decision has been made to initiate a treatment with Tofacitinib.
Patient with at least minimal level of depression (CUDOS questionnaire ≥11 points).
Capable of understanding and signing a written informed consent form.
Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study is a requirement for inclusion into this study.
You may not be if
Patients unwilling/unable to fill in printed patient questionnaires.
Clareo Health | Changes of Depression After First-year of Tofacitinib in RA Patients
